Discovering The Potential of CCNB2 as A Drug Target and Biomarker for NSC

Discovering The Potential of CCNB2 as A Drug Target and Biomarker for NSC

The Comprehensive Cancer Database (CCDB) is a comprehensive online database that provides information on various types of cancer, including neurobladder cancer (NSC). One of the most promising drugs currently in clinical trials for NSC is CCNB2-HUMAN. In this article, we will discuss the potential of CCNB2 as a drug target and its potential as a biomarker for the treatment of NSC.

Potential Drug Target

CCNB2 is a protein that is expressed in various tissues and has been shown to be involved in the development and progression of cancer. Several studies have suggested that CCNB2 may be a potential drug target for NSC.

One of the reasons for the potential of CCNB2 as a drug target is its involvement in the cell signaling pathway known as the TGF-β pathway. The TGF-β pathway is a well-established pathway that is involved in the development and maintenance of tissues, including neural cells. Several studies have shown that changes in the TGF-β pathway have been associated with the development of NSC.

In addition, CCNB2 has been shown to play a role in the regulation of cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. The TGF-β pathway is involved in the regulation of cell adhesion, and changes in this pathway have been linked to the development of NSC.

Potential Biomarker

In addition to its potential as a drug target, CCNB2 has also been shown to be a potential biomarker for the treatment of NSC. The use of biomarkers can help doctors to better understand the progress of a patient's cancer and to determine the effectiveness of a given treatment.

One of the reasons for the potential of CCNB2 as a biomarker is its expression in various tissues, including cancer cells. This means that changes in the level of CCNB2 expression can be an indicator of the effectiveness of a treatment.

Another potential biomarker for NSC is its role in the regulation of cell proliferation. The TGF-β pathway is involved in the regulation of cell proliferation, and changes in this pathway have been linked to the development of NSC.

Conclusion

In conclusion, CCNB2 is a protein that has been shown to be involved in the development and progression of cancer, including NSC. The potential of CCNB2 as a drug target and biomarker make it an attractive target for further research. Further studies are needed to fully understand the role of CCNB2 in the treatment of NSC and to determine its potential as a drug.

Protein Name: Cyclin B2

Functions: Essential for the control of the cell cycle at the G2/M (mitosis) transition

The "CCNB2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCNB2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CCNB2P1 | CCNB3 | CCNC | CCND1 | CCND2 | CCND2-AS1 | CCND3 | CCNDBP1 | CCNE1 | CCNE2 | CCNF | CCNG1 | CCNG2 | CCNH | CCNI | CCNI2 | CCNJ | CCNJL | CCNK | CCNL1 | CCNL2 | CCNO | CCNP | CCNQ | CCNQP1 | CCNT1 | CCNT2 | CCNT2-AS1 | CCNT2P1 | CCNY | CCNYL1 | CCNYL2 | CCP110 | CCPG1 | CCR1 | CCR10 | CCR12P | CCR2 | CCR3 | CCR4 | CCR4-NOT transcription complex | CCR5 | CCR5AS | CCR6 | CCR7 | CCR8 | CCR9 | CCRL2 | CCS | CCSAP | CCSER1 | CCSER2 | CCT2 | CCT3 | CCT4 | CCT5 | CCT6A | CCT6B | CCT6P1 | CCT6P3 | CCT7 | CCT8 | CCT8L1P | CCT8L2 | CCT8P1 | CCZ1 | CCZ1B | CCZ1P-OR7E38P | CD101 | CD101-AS1 | CD109 | CD14 | CD151 | CD160 | CD163 | CD163L1 | CD164 | CD164L2 | CD177 | CD177P1 | CD180 | CD19 | CD1A | CD1B | CD1C | CD1D | CD1E | CD2 | CD200 | CD200R1 | CD200R1L | CD207 | CD209 | CD22 | CD226 | CD24 | CD244 | CD247 | CD248 | CD24P2